Tuesday, November 24, 2009, 8:16pm SGT - The Singapore stock market is closed.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

Elite Pharmaceuticals Inc. (ELTP.OB)

At 4:59AM SGT: 0.096 USD   0.00 (0.00%)  
 MORE ON ELTP.OB 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 ELITE PHARMA INC (OTC BB:ELTP.OB) Delayed quote dataEdit
Last Trade:0.096 USD
Trade Time:4:59AM SGT
Change: 0.00 (0.00%)
Prev Close:0.096
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:4.00
Day's Range:N/A - N/A
52wk Range:0.03 - 0.34
Volume:0
Avg Vol (3m):466,803
Market Cap:6.72M
P/E (ttm):N/A
EPS (ttm):-0.113
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Use Y! Toolbar to track stocks
 Add ELTP.OB to Portfolio   Download Data

 HEADLINES 
•ELITE PHARMACEUTICALS INC /DE/ Financials
EDGAR Online Financials (Fri, Nov 20)
•Q2 2009 ELITE PHARMACEUTICALS INC Earnings Release - Time Not Supplied
CCBN (Wed, Nov 18)
•Elite Pharmaceuticals, Inc. to Host Quarterly Conference Call on Wednesday, November 18, 2009
GlobeNewswire (Mon, Nov 16)
•ELITE PHARMACEUTICALS INC /DE/ Files SEC form 10-Q, Quarterly Report
EDGAR Online (Mon, Nov 16)
•ELITE PHARMACEUTICALS INC /DE/ Files SEC form 8-K, Unregistered Sale of Equity Securities, Other Events
EDGAR Online (Fri, Nov 6)
•Elite Pharmaceuticals, Inc. Announces Second Closing of Strategic Alliance Agreement With Epic Pharma
GlobeNewswire (Thu, Nov 5)
•ELITE PHARMACEUTICALS INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Thu, Oct 1)
•ELITE PHARMACEUTICALS INC /DE/ Files SEC form 8-K/A, Change in Directors or Principal Officers, Financial Statements
EDGAR Online (Sat, Sep 26)
•ELITE PHARMACEUTICALS INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements an
EDGAR Online (Tue, Sep 22)
•Elite Pharmaceuticals Appoints Chief Executive Officer and Chief Scientific Officer
GlobeNewswire (Tue, Sep 22)
More Headlines for ELTP.OB...
 ANALYST 
EPS Est (next year) (Mar-10) :N/A
EPS Est (in 2 years) (Mar-11) :N/A
Avg Rec (current)*:2.0
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Elite Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, manufacture, and license of orally administered controlled release drug delivery systems and products in the United States.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices